In-Vitro Diagnostics (IVD) Market By Products (Reagents, Instruments, Software And Services), By Techniques (Clinical Chemistry, Immunochemistry/ Immunoassays, Hematology, Coagulation And Hemostasis, Microbiology, Molecular Diagnostics (MDX)), By Test Locations (Point-Of-Care Testing, Central Lab Testing, OTC/Self Testing) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

The global in-vitro diagnostics (IVD) market has considerably evolved over the past decade with innovative diagnosis options. Significant factors contributing to the growth of the in-vitro diagnostics market include the growing incidence of chronic diseases, the aging population, and the growing demand for point-of-care testing. In addition, advancements in genomics and proteomics, the introduction of condition-specific markers, and the development of healthcare infrastructure in emerging economies create prospects for the market.

This report studies the global in-vitro diagnostics market on the basis of four major segmentations: products, techniques, test locations, and geography. Reagents, instruments, software, and services make the IVD market by products. Clinical chemistry, immunochemistry/immunoassays, hematology, coagulation and hemostasis, microbiology, molecular diagnostics (MDX), and others are the IVD techniques studied in the report. IVD is practiced across point-of-care testing, central lab testing, and OTC/self-testing based on test locations. Each of the mentioned segments is analyzed for its market size, forecast, and major trends observed in each category. The market size and forecast are provided for 2014-2022 with the individual compounded annual growth rates (CAGR %) for 2016-2022 while considering 2015 as the base year.

Based on geographical distribution, the global in-vitro diagnostics market is studied for North America, Europe, Asia-Pacific, Middle East, Africa, and Latin America regional markets. Analysis of key country-level markets for major regional markets is also provided in this study. Market size and forecast for each region and the country-level market are provided in this report for 2014-2022, along with their respective CAGRs during 2016-2022, considering 2015 as the base year.

This distribution is elucidated as follows:

  • North America
  • US.
  • Canada
  • Europe
  • UK.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

Along with the quantitative data, qualitative information sets such as market dynamics and executive summary for the global in-vitro diagnostics market are included in the report. Fractal map analysis and attractive investment proposition tools are also included in the report or competition assessment. This study concludes with the company profiles section, which includes major information about the key companies engaged in developing, manufacturing, and selling IVD technologies.

Frequently asked questions :

The market for In-Vitro Diagnostics (IVD) Market is expected to reach US$ 81,345.1 Bn by 2022

The In-Vitro Diagnostics (IVD) Market is expected to see significant CAGR growth over the coming years, at 4.2%.

The report is forecasted from 2016-2022.

The base year of this report is 2015.

Abbott Laboratories, Inc., Bayer AG., Becton, Dickson and Company, bioMérieux, Bio-Rad Laboratories, Inc.are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  May 2016
Category:  Pharmaceuticals
Report ID:   57810
Report Format:   PDF
Pages:   120
Rating:    4.4 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support